Phase capabilities Advanced Pharma – Miami operates a 40,000 sq. ft turnkey facility with a 100+ bed Phase I unit and IPUs, indicating strong early to mid-phase clinical trial capacity that can be leveraged to upsell sponsors seeking scalable Phase I to IV services.

Expertise depth With principals and a team boasting 50 plus years of combined research experience across multiple specialties, the facility can position itself as a trusted partner for complex clinical programs, appealing to sponsors needing high-quality data and experienced site investigators.

Strong recruitment Historical recruitment and retention in the upper 90s suggests superior patient engagement and study timelines, a key selling point for sponsors facing recruitment bottlenecks and deadline-driven trials.

Quality and compliance Emphasis on strict protocol adherence and GCP standards provides a differentiator for sponsors prioritizing data integrity and regulatory compliance, supporting conversations around risk mitigation and audit readiness.

Growth opportunities Revenue in the reported range and a broad capability set imply potential cross-sell to larger biotech and pharma players seeking comprehensive Phase I–IV services, including integration with device and biotech trial regimes to expand market reach.